COMMENTARY

• Will Drugs that Fight Cancer Stem Cells Succeed? Domestic Clinical Trial by DSP on the Horizon
  March 15, 2013

• Gov’t, Industry to Support Developing Countries through Development of Drugs for Infectious Diseases; Hoping to Secure Future Business Opportunities as Well
  February 27, 2013

• What Next for a “Mature” ICH? What More Can Be Done Beyond Regulatory Harmonization?
  January 22, 2013

• Hot Products in 2013: New Drugs Likely to Jolt RA Treatment, Anticoagulant Markets
  January 8, 2013

• Counterfeit Drugs: Risks Lurking in Globalization
  December 28, 2012

• Can Japan Craft Its Own “Compassionate Use” System without Spoiling Drug Makers’ Development Drives?
  December 7, 2012

• Recent Announcements of Suspended Product Supplies Highlight Supply Risks Faced by Generic Drug Industry
  November 27, 2012

• Will Integration of Domestic Makers Be Enough for Sustainable Plasma Fractionation Operations?
  November 16, 2012

• Approval of Switch-OTC Epadel Puts Spotlight on Quality, Track Record of Pharmacists
  November 9, 2012

• Final Preparations Underway for Trial Run of Medical Database
  September 25, 2012

• Competition Getting Fiercer in COPD Drug Market
  September 13, 2012

• FY2013 Budget Expected to Have Positive Impact on Pharmaceutical and Medical Device Industries
  August 30, 2012

• Pharmaceutical Bar Coding Initiatives Spreading Among Western Countries
  August 21, 2012

• Government Shows Consideration towards Municipalities on IPV Price Issue
  August 14, 2012

• Challenges Emerging from Hiroshima: Improvement of Wholesalers' “Services of Convenience”
  August 1, 2012

• Integration of Advanced Healthcare System to Strengthen Linkage Between Development, Insurance, and Regulatory Approval
  July 10, 2012

• Major Generic Drug Makers Trying New Strategies to Boost Product Strengths
  July 6, 2012

• Gov’t to Support Development of Innovative Drugs of Japanese Origin through Drug Discovery Support Network
  June 22, 2012

• Discussions on Long-Listed Drugs Must Balance Interests of All Stakeholders
  June 14, 2012

• Supply of New Drugs Prior to NHI Price Listing to Increase as More Makers Target Drugs with Unmet Medical Needs
  April 20, 2012

ページ